Keyphrases
Insulinoma
100%
Finland
76%
Hemoglobin A1c (HbA1c)
76%
Diabetes Management
66%
Diabetic Ketoacidosis
40%
Diabetes
40%
Clinical Characteristics
37%
Insulin
36%
Recombinant Human
33%
Life Studies
33%
Long-term Morbidity
33%
Receptor Expression
33%
Long-term Health
33%
Clinical Prognosis
33%
Human Immunodeficiency virus-1 Infection
33%
Human Immunodeficiency Virus Type 1 (HIV-1)
33%
Negative Factors
33%
Sensoring
33%
Circumscribed Scleroderma
33%
Erythema Chronicum Migrans
33%
Borrelia Burgdorferi
33%
A1 Receptor
33%
Health-related Quality of Life
33%
Insulin Delivery
33%
AIDS/HIV
33%
Glucagon-like
33%
Glycemic Control
33%
Interprofessional Education
33%
Long-term Mortality
33%
OspA
27%
Time in Range
23%
Morphea
22%
Nursing Students
20%
Polymerase Chain Reaction
16%
Malignant Insulinoma
14%
Insulin Dose
13%
Glucose Sensor
13%
Acute Complications
13%
Diabetes Knowledge
13%
Intermittently Scanned CGM
13%
Continuous Subcutaneous Insulin Infusion
13%
Education Courses
13%
Lymphocytoma
11%
Antibody Response
11%
Reaction-based
11%
Olla
11%
Long-term Prognosis
9%
Endocrine Disorders
9%
Atrial Fibrillation
9%
Intestinal Obstruction
9%
Medicine and Dentistry
Nesidioblastosis
66%
Receptor Expression
33%
Glucagon Like Peptide 1 Receptor
33%
Diabetic Ketoacidosis
33%
Quality of Life
33%
Erythema Chronicum Migrans
33%
Borrelia burgdorferi
33%
Morphea
33%
Polymerase Chain Reaction
16%
Metastatic Carcinoma
10%
Neoplasm
10%
Diabetes
8%
Population
7%
Pancreas Tumor
7%
Metastasis Potential
6%
Early Diagnosis
5%
Flagellin
5%
Skin Manifestation
5%
Diagnosis
5%
Membrane Protein
5%
Amplicon
5%
Oligonucleotide
5%
Nucleotide Sequence
5%
Dermatosis
5%
Lyme Borreliosis
5%
Skin Biopsy
5%
Localized Scleroderma
5%
Acrodermatitis Chronica Atrophicans
5%
Immunoglobulin M Antibody
5%
Hemoglobin A1c
5%
Skin Defect
5%
